Induction maintenance with tumour necrosis factor-inhibitor combination therapy with discontinuation versus methotrexate monotherapy in early rheumatoid arthritis: a systematic review and meta-analysis of efficacy in randomised controlled trials

Ítems similars

• Low rates of remission with methotrexate monotherapy in rheumatoid arthritis: review of randomised controlled trials could point towards a paradigm shift
  per: Chatzidionysiou, Katerina, et al.
  Publicat: (2019)
• Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial
  per: Westhovens, René, et al.
  Publicat: (2021)
• Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis
  per: Fleischmann, Roy M, et al.
  Publicat: (2016)
• A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission
  per: Chatzidionysiou, Katerina, et al.
  Publicat: (2016)
• Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial
  per: Burmester, Gerd R, et al.
  Publicat: (2017)